Cargando…

Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?

Detalles Bibliográficos
Autores principales:	Behling, Felix, Paßlack, Peter, Fodi, Christina-Katharina, Hielscher, Thomas, Schittenhelm, Jens, Nassiri, Farshad, Wang, Justin Z, Zadeh, Gelareh, Tabatabai, Ghazaleh, Sahm, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506376/ https://www.ncbi.nlm.nih.gov/pubmed/37727848 http://dx.doi.org/10.1093/noajnl/vdad112

Ejemplares similares

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
por: Behling, Felix, et al.
Publicado: (2020)

Increased proliferation is associated with CNS invasion in meningiomas
por: Behling, Felix, et al.
Publicado: (2021)

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
por: Behling, Felix, et al.
Publicado: (2020)

CNS Invasion in Meningioma—How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence
por: Behling, Felix, et al.
Publicado: (2020)

The prognostic role of the immunohistochemical expression of S100 in meningiomas
por: Behling, Felix, et al.
Publicado: (2022)

Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
por: Behling, Felix, et al.
Publicado: (2021)

The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
por: Fodi, Christina, et al.
Publicado: (2021)

Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
por: Fodi, Christina, et al.
Publicado: (2022)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
por: Fodi, Christina-Katharina, et al.
Publicado: (2022)

COMPREHENSIVE MULTIPLATFORM ANALYSIS OF CDKN2A ALTERATIONS IN MENINGIOMAS
por: Wang, Justin Z, et al.
Publicado: (2023)

Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
por: Hoffmann, Elgin, et al.
Publicado: (2021)

Integrative assessment of brain and bone invasion in meningioma patients
por: Zwirner, Kerstin, et al.
Publicado: (2019)

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Introduction: Ongoing clinical challenges in the management of meningiomas and future directions
por: Wang, Justin Z, et al.
Publicado: (2023)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring
por: Behling, Felix, et al.
Publicado: (2021)

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
por: Engelhardt, Sophie, et al.
Publicado: (2022)

The multiomic landscape of meningiomas: a review and update
por: Wang, Justin Z., et al.
Publicado: (2023)

COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma
por: Behling, Felix, et al.
Publicado: (2021)

Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors
por: Bunda, Severa, et al.
Publicado: (2021)

DNA methylation profiling of a lipomatous meningioma: illustrative case
por: Patel, Zeel, et al.
Publicado: (2023)

Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort
por: Gonçalves, Vítor Moura, et al.
Publicado: (2021)

Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13, 466
por: Gonçalves, Vítor Moura, et al.
Publicado: (2023)

Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging
por: Nuessle, Nils C., et al.
Publicado: (2021)

A molecularly integrated grade for meningioma
por: Driver, Joseph, et al.
Publicado: (2021)

Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
por: Karimi, Shirin, et al.
Publicado: (2021)

Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
por: Karimi, Shirin, et al.
Publicado: (2020)

Dendritic cell vaccines for high-grade gliomas
por: Eagles, Matthew E, et al.
Publicado: (2018)

How to live with a meningioma: experiences, symptoms, and challenges reported by patients
por: Nassiri, Farshad, et al.
Publicado: (2020)

Transition of a vestibular schwannoma to a malignant peripheral nerve sheath tumor with loss of H3K27 trimethylation after radiosurgery—a case report and review of the literature
por: Behling, Felix, et al.
Publicado: (2021)

Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging
por: Hempel, Johann-Martin, et al.
Publicado: (2021)

Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification
por: Deng, Maximilian Y, et al.
Publicado: (2023)

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake
por: Behling, Felix, et al.
Publicado: (2019)

Oncogenic BRAF Alterations and Their Role in Brain Tumors
por: Behling, Felix, et al.
Publicado: (2019)

Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Differences in intraoperative sampling during meningioma surgery regarding CNS invasion – Results of a survey on behalf of the EANS skull base section
por: Behling, Felix, et al.
Publicado: (2023)

Meningiomas with CNS invasion
por: Gousias, Konstantinos, et al.
Publicado: (2023)

Introduction to the mini‐symposium “molecular neuropathology of meningioma”
por: Sahm, Felix, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tu64g1hlfnmev29ovjef0junnn